強直性脊椎炎治療薬の世界市場（～2026年）

• 英文タイトル：Global Ankylosing Spondylitis Drug Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY10853
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は強直性脊椎炎治療薬のグローバル市場について調査・分析したレポートです。種類別（セルトリズマブ、エンブレル、フミラ、レミケード、シンポニー、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別強直性脊椎炎治療薬の競争状況、市場シェア
・世界の強直性脊椎炎治療薬市場：種類別市場規模 2015年-2020年（セルトリズマブ、エンブレル、フミラ、レミケード、シンポニー、その他）
・世界の強直性脊椎炎治療薬市場：種類別市場規模予測 2021年-2026年（セルトリズマブ、エンブレル、フミラ、レミケード、シンポニー、その他）
・世界の強直性脊椎炎治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック）
・世界の強直性脊椎炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック）
・北米の強直性脊椎炎治療薬市場分析：米国、カナダ
・ヨーロッパの強直性脊椎炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの強直性脊椎炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の強直性脊椎炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの強直性脊椎炎治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Amgen、Wyeth、Takeda、Centocor、Schering-Plough、Mitsubishi Tanabe、Abbott、Eisai、Pfizer、Johnson & Johnson
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market
The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Ankylosing Spondylitis Drug Scope and Market Size
Ankylosing Spondylitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ankylosing Spondylitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson

Market segment by Type, the product can be split into
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
1.4 Market by Type
1.4.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cimzia
1.4.3 Enbrel
1.4.4 Humira
1.4.5 Remicade
1.4.6 Simponi
1.4.7 Others
1.5 Market by Application
1.5.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Ankylosing Spondylitis Drug Market Perspective (2015-2026)
2.2 Global Ankylosing Spondylitis Drug Growth Trends by Regions
2.2.1 Ankylosing Spondylitis Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ankylosing Spondylitis Drug Historic Market Share by Regions (2015-2020)
2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ankylosing Spondylitis Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Ankylosing Spondylitis Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Ankylosing Spondylitis Drug Players by Market Size
3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2015-2020)
3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ankylosing Spondylitis Drug Market Concentration Ratio
3.2.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2019
3.3 Ankylosing Spondylitis Drug Key Players Head office and Area Served
3.4 Key Players Ankylosing Spondylitis Drug Product Solution and Service
3.5 Date of Enter into Ankylosing Spondylitis Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2015-2020)
4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Ankylosing Spondylitis Drug Market Size by Application (2015-2020)
5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Ankylosing Spondylitis Drug Market Size (2015-2020)
6.2 Ankylosing Spondylitis Drug Key Players in North America (2019-2020)
6.3 North America Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
6.4 North America Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

7 Europe
7.1 Europe Ankylosing Spondylitis Drug Market Size (2015-2020)
7.2 Ankylosing Spondylitis Drug Key Players in Europe (2019-2020)
7.3 Europe Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
7.4 Europe Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

8 China
8.1 China Ankylosing Spondylitis Drug Market Size (2015-2020)
8.2 Ankylosing Spondylitis Drug Key Players in China (2019-2020)
8.3 China Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
8.4 China Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

9 Japan
9.1 Japan Ankylosing Spondylitis Drug Market Size (2015-2020)
9.2 Ankylosing Spondylitis Drug Key Players in Japan (2019-2020)
9.3 Japan Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
9.4 Japan Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Ankylosing Spondylitis Drug Market Size (2015-2020)
10.2 Ankylosing Spondylitis Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

11 India
11.1 India Ankylosing Spondylitis Drug Market Size (2015-2020)
11.2 Ankylosing Spondylitis Drug Key Players in India (2019-2020)
11.3 India Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
11.4 India Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Ankylosing Spondylitis Drug Market Size (2015-2020)
12.2 Ankylosing Spondylitis Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Ankylosing Spondylitis Drug Market Size by Type (2015-2020)
12.4 Central & South America Ankylosing Spondylitis Drug Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview
13.1.3 Amgen Ankylosing Spondylitis Drug Introduction
13.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Wyeth
13.2.1 Wyeth Company Details
13.2.2 Wyeth Business Overview
13.2.3 Wyeth Ankylosing Spondylitis Drug Introduction
13.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.2.5 Wyeth Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview
13.3.3 Takeda Ankylosing Spondylitis Drug Introduction
13.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Centocor
13.4.1 Centocor Company Details
13.4.2 Centocor Business Overview
13.4.3 Centocor Ankylosing Spondylitis Drug Introduction
13.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.4.5 Centocor Recent Development
13.5 Schering-Plough
13.5.1 Schering-Plough Company Details
13.5.2 Schering-Plough Business Overview
13.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction
13.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.5.5 Schering-Plough Recent Development
13.6 Mitsubishi Tanabe
13.6.1 Mitsubishi Tanabe Company Details
13.6.2 Mitsubishi Tanabe Business Overview
13.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction
13.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.6.5 Mitsubishi Tanabe Recent Development
13.7 Abbott
13.7.1 Abbott Company Details
13.7.2 Abbott Business Overview
13.7.3 Abbott Ankylosing Spondylitis Drug Introduction
13.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.7.5 Abbott Recent Development
13.8 Eisai
13.8.1 Eisai Company Details
13.8.2 Eisai Business Overview
13.8.3 Eisai Ankylosing Spondylitis Drug Introduction
13.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.8.5 Eisai Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview
13.9.3 Pfizer Ankylosing Spondylitis Drug Introduction
13.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview
13.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction
13.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Ankylosing Spondylitis Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
Table 3. Ranking of Global Top Ankylosing Spondylitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cimzia
Table 6. Key Players of Enbrel
Table 7. Key Players of Humira
Table 8. Key Players of Remicade
Table 9. Key Players of Simponi
Table 10. Key Players of Others
Table 11. Global Ankylosing Spondylitis Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Ankylosing Spondylitis Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Ankylosing Spondylitis Drug Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Ankylosing Spondylitis Drug Market Share by Regions (2015-2020)
Table 15. Global Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Ankylosing Spondylitis Drug Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Ankylosing Spondylitis Drug Market Growth Strategy
Table 21. Main Points Interviewed from Key Ankylosing Spondylitis Drug Players
Table 22. Global Ankylosing Spondylitis Drug Revenue by Players (2015-2020) (Million US$)
Table 23. Global Ankylosing Spondylitis Drug Market Share by Players (2015-2020)
Table 24. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2019)
Table 25. Global Ankylosing Spondylitis Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Ankylosing Spondylitis Drug Product Solution and Service
Table 28. Date of Enter into Ankylosing Spondylitis Drug Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 31. Global Ankylosing Spondylitis Drug Market Size Share by Type (2015-2020)
Table 32. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2021-2026)
Table 33. Global Ankylosing Spondylitis Drug Market Size Share by Application (2015-2020)
Table 34. Global Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 35. Global Ankylosing Spondylitis Drug Market Size Share by Application (2021-2026)
Table 36. North America Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 38. North America Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 39. North America Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 40. North America Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 41. North America Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 42. Europe Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 44. Europe Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 46. Europe Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 48. China Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 49. China Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 50. China Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 51. China Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 52. China Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 53. China Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 54. Japan Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 56. Japan Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 58. Japan Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 62. Southeast Asia Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 64. Southeast Asia Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 66. India Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 67. India Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 68. India Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 69. India Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 70. India Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 71. India Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Ankylosing Spondylitis Drug Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Ankylosing Spondylitis Drug Market Share (2019-2020)
Table 74. Central & South America Ankylosing Spondylitis Drug Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Ankylosing Spondylitis Drug Market Share by Type (2015-2020)
Table 76. Central & South America Ankylosing Spondylitis Drug Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Ankylosing Spondylitis Drug Market Share by Application (2015-2020)
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Product
Table 81. Amgen Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 82. Amgen Recent Development
Table 83. Wyeth Company Details
Table 84. Wyeth Business Overview
Table 85. Wyeth Product
Table 86. Wyeth Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 87. Wyeth Recent Development
Table 88. Takeda Company Details
Table 89. Takeda Business Overview
Table 90. Takeda Product
Table 91. Takeda Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 92. Takeda Recent Development
Table 93. Centocor Company Details
Table 94. Centocor Business Overview
Table 95. Centocor Product
Table 96. Centocor Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 97. Centocor Recent Development
Table 98. Schering-Plough Company Details
Table 99. Schering-Plough Business Overview
Table 100. Schering-Plough Product
Table 101. Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 102. Schering-Plough Recent Development
Table 103. Mitsubishi Tanabe Company Details
Table 104. Mitsubishi Tanabe Business Overview
Table 105. Mitsubishi Tanabe Product
Table 106. Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 107. Mitsubishi Tanabe Recent Development
Table 108. Abbott Company Details
Table 109. Abbott Business Overview
Table 110. Abbott Product
Table 111. Abbott Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 112. Abbott Recent Development
Table 113. Eisai Business Overview
Table 114. Eisai Product
Table 115. Eisai Company Details
Table 116. Eisai Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 117. Eisai Recent Development
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Product
Table 121. Pfizer Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 122. Pfizer Recent Development
Table 123. Johnson & Johnson Company Details
Table 124. Johnson & Johnson Business Overview
Table 125. Johnson & Johnson Product
Table 126. Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2015-2020) (Million US$)
Table 127. Johnson & Johnson Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ankylosing Spondylitis Drug Market Share by Type: 2020 VS 2026
Figure 2. Cimzia Features
Figure 3. Enbrel Features
Figure 4. Humira Features
Figure 5. Remicade Features
Figure 6. Simponi Features
Figure 7. Others Features
Figure 8. Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ankylosing Spondylitis Drug Report Years Considered
Figure 12. Global Ankylosing Spondylitis Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Ankylosing Spondylitis Drug Market Share by Regions: 2020 VS 2026
Figure 14. Global Ankylosing Spondylitis Drug Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Ankylosing Spondylitis Drug Market Share by Players in 2019
Figure 17. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Drug Revenue in 2019
Figure 19. North America Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Ankylosing Spondylitis Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

強直性脊椎炎治療の世界市場（～2026年）

Global Ankylosing Spondylitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY10854 2020年11月25日 99Pages
当調査資料は強直性脊椎炎治療のグローバル市場について調査・分析したレポートです。種類別（疾患修飾性抗リウマチ薬（DMARD）、非ステロイド性抗炎症薬（NSAID）、生物学的製剤）市場規模、用途別（若年、成人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

ドラッグデリバリーシステム（DDS）の世界市場（～2026年）

Global Drug Delivery Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY11715 2020年11月25日 96Pages
当調査資料はドラッグデリバリーシステム（DDS）のグローバル市場について調査・分析したレポートです。種類別（子宮内インプラント、プロドラッグインプラント、ポリマードラッグデリバリー、標的化ドラッグデリバリー）市場規模、用途別（感染症、腫瘍、泌尿器科、糖尿病、中枢神経系）市場規模、地域別（北米、米国、...

OTC薬の世界市場（～2026年）

Global Over-the-Counter Drug Market Size, Status and Forecast 2020-2026
MRC2-11QY04133 2020年11月20日 98Pages
当調査資料はOTC薬のグローバル市場について調査・分析したレポートです。種類別（栄養補助食品、胃腸薬、鎮痛剤、呼吸器系薬）市場規模、用途別（病院、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

経鼻ドラッグデリバリーの世界市場（～2026年）

Global Nasal Drug Delivery Market Size, Status and Forecast 2020-2026
MRC2-11QY03911 2020年11月20日 92Pages
当調査資料は経鼻ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（単位用量、複数用量、計量用量）市場規模、用途別（アレルギー性および非アレルギー性鼻炎、鼻づまり、予防接種）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

ドラッグデリバリー技術の世界市場（～2026年）

Global Drug Delivery Technologies Market Size, Status and Forecast 2020-2026
MRC2-11QY11716 2020年11月25日 90Pages
当調査資料はドラッグデリバリー技術のグローバル市場について調査・分析したレポートです。種類別（経口ドラッグデリバリー、肺ドラッグデリバリー、注射薬デリバリー、眼ドラッグデリバリー、経鼻ドラッグデリバリー、局所ドラッグデリバリー、埋め込み型ドラッグデリバリー、経粘膜ドラッグデリバリー）市場規模、用途別...

ナノテクノロジードラッグデリバリーの世界市場（～2026年）

Global Nanotechnology Drug Delivery Market Size, Status and Forecast 2020-2026
MRC2-11QY03901 2020年11月20日 90Pages
当調査資料はナノテクノロジードラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（ナノ結晶、ナノ粒子、リポソーム、ミセル、ナノチューブ、その他）市場規模、用途別（神経学、腫瘍学、心臓血管/生理学、抗炎症/免疫学、抗感染症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッ...

局所ドラッグデリバリーシステムの世界市場（～2026年）

Global Topical Drug Delivery System Market Size, Status and Forecast 2020-2026
MRC2-11QY04865 2020年11月20日 96Pages
当調査資料は局所ドラッグデリバリーシステムのグローバル市場について調査・分析したレポートです。種類別（皮膚ドラッグデリバリー、眼科ドラッグデリバリー、直腸ドラッグデリバリー、膣ドラッグデリバリー、経鼻ドラッグデリバリー）市場規模、用途別（病院・私立クリニック、在宅介護施設、その他）市場規模、地域別（...

小分子創薬の世界市場（～2026年）

Global Small-Molecule Drug Discovery Market Size, Status and Forecast 2020-2026
MRC2-11QY04656 2020年11月20日 99Pages
当調査資料は小分子創薬のグローバル市場について調査・分析したレポートです。種類別（丸薬、錠剤、その他）市場規模、用途別（腫瘍、心臓血管、皮膚科、中枢神経系、呼吸器、胃腸、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

徐放性ドラッグデリバリーの世界市場（～2026年）

Global Controlled Release Drug Delivery Market Size, Status and Forecast 2020-2026
MRC2-11QY11499 2020年11月25日 99Pages
当調査資料は徐放性ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（ワースターテクニック、コアセルベーション、マイクロカプセル化、インプラント、経皮、標的化送達、その他）市場規模、用途別（定量吸入器、注射剤、経皮・眼パッチ、輸液ポンプ、経口制御薬物送達システム、薬剤溶出ス...

自己免疫治療薬の世界市場（～2026年）

Global Autoimmune Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY10931 2020年11月25日 93Pages
当調査資料は自己免疫治療薬のグローバル市場について調査・分析したレポートです。種類別（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE））市場規模、用途別（病院、在宅医療、専門クリニック）市場規模、地域別（北米、米国、カナ...

強直性脊椎炎治療の世界市場（～2026年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…
創薬アウトソーシングの世界市場（～2026年） Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking …
腫瘍壊死因子阻害薬の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Drug Market The global Tumor Necrosis Factor Inhibitors Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Drug S…
深部静脈血栓症（DVT）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Deep Vein Thrombosis (DVT) Drug Scope and Market Si…
NSAID治療薬の世界市場（～2026年） Market Analysis and Insights: Global NSAIDs Drug Market The global NSAIDs Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global NSAIDs Drug Scope and Market Size NSAIDs Drug market is segmented by Type, and by Applicati…